Literature DB >> 26306647

Defining the role of the CGGBP1 protein in FMR1 gene expression.

Martina Goracci1, Stella Lanni1, Giorgia Mancano1, Federica Palumbo1, Pietro Chiurazzi1, Giovanni Neri1, Elisabetta Tabolacci1.   

Abstract

Fragile X syndrome is the most common heritable form of intellectual disability and is caused by the expansion over 200 repeats and subsequent methylation of the CGG triplets at the 5' UTR of the FMR1 gene, leading to its silencing. The epigenetic and molecular mechanisms responsible for FMR1 gene silencing are not fully clarified. To identify structure-specific proteins that could recruit components of the silencing machinery we investigated the role of CGGBP1 in FMR1 gene transcription. CGGBP1 is a highly conserved protein that binds specifically to unmethylated CGG tracts. Its role on FMR1 transcription is yet to be defined. Sequencing analysis and expression studies through quantitative PCR of CGGBP1 were performed in cell lines with different allele expansions: wild type, premutation, methylated full mutation and unmethylated full mutation, demonstrating no differences between them. ChIP assays clearly demonstrated that CGGBP1 binds to unmethylated CGG triplets of the FMR1 gene, but not to methylated CGGs. We also observed that CGGBP1 binding to the FMR1 locus was restored after pharmacological demethylation, with 5-azadC, of alleles, carriers of methylated full mutation, suggesting a possible role for CGGBP1 in FMR1 expression. CGGBP1 silencing with shRNAs (reaching ~98% of CGGBP1-mRNA depletion) did not affect FMR1 transcription and CGG expansion stability in expanded alleles. Although the strong binding to the CGG tract could suggest a relevant role of CGGBP1 on FMR1 gene expression, our results demonstrate that CGGBP1 has no direct effect on FMR1 transcription and CGG repeat stability.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26306647      PMCID: PMC4930089          DOI: 10.1038/ejhg.2015.182

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  27 in total

1.  Gene structure and expression of the 5'-(CGG)(n)-3'-binding protein (CGGBP1).

Authors:  Frauke Naumann; Ralph Remus; Birgit Schmitz; Walter Doerfler
Journal:  Genomics       Date:  2004-01       Impact factor: 5.736

Review 2.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

Review 3.  The FRAXopathies: definition, overview, and update.

Authors:  Filomena Pirozzi; Elisabetta Tabolacci; Giovanni Neri
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

4.  The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome.

Authors:  Daman Kumari; Karen Usdin
Journal:  Hum Mol Genet       Date:  2010-09-14       Impact factor: 6.150

5.  A small molecule regulates hairpin structures in d(CGG) trinucleotide repeats.

Authors:  Masaki Hagihara; Hanping He; Maki Kimura; Kazuhiko Nakatani
Journal:  Bioorg Med Chem Lett       Date:  2012-01-25       Impact factor: 2.823

6.  Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.

Authors:  Dilek Colak; Nikica Zaninovic; Michael S Cohen; Zev Rosenwaks; Wang-Yong Yang; Jeannine Gerhardt; Matthew D Disney; Samie R Jaffrey
Journal:  Science       Date:  2014-02-28       Impact factor: 47.728

7.  Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.

Authors:  Roberta Pietrobono; Maria Grazia Pomponi; Elisabetta Tabolacci; Ben Oostra; Pietro Chiurazzi; Giovanni Neri
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

8.  Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations.

Authors:  Elisabetta Tabolacci; Umberto Moscato; Francesca Zalfa; Claudia Bagni; Pietro Chiurazzi; Giovanni Neri
Journal:  Eur J Hum Genet       Date:  2008-07-16       Impact factor: 4.246

9.  CGGBP1 regulates cell cycle in cancer cells.

Authors:  Umashankar Singh; Pernilla Roswall; Lene Uhrbom; Bengt Westermark
Journal:  BMC Mol Biol       Date:  2011-07-07       Impact factor: 2.946

10.  Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments.

Authors:  Elisabetta Tabolacci; Roberta Pietrobono; Umberto Moscato; Ben A Oostra; Pietro Chiurazzi; Giovanni Neri
Journal:  Eur J Hum Genet       Date:  2005-05       Impact factor: 4.246

View more
  3 in total

1.  CGGBP1-regulated cytosine methylation at CTCF-binding motifs resists stochasticity.

Authors:  Manthan Patel; Divyesh Patel; Subhamoy Datta; Umashankar Singh
Journal:  BMC Genet       Date:  2020-07-29       Impact factor: 2.797

Review 2.  DNA Methylation, Mechanisms of FMR1 Inactivation and Therapeutic Perspectives for Fragile X Syndrome.

Authors:  Veronica Nobile; Cecilia Pucci; Pietro Chiurazzi; Giovanni Neri; Elisabetta Tabolacci
Journal:  Biomolecules       Date:  2021-02-16

Review 3.  Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome.

Authors:  Elisabetta Tabolacci; Federica Palumbo; Veronica Nobile; Giovanni Neri
Journal:  Genes (Basel)       Date:  2016-08-17       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.